/home/corante/public_html/pipeline/ en-us derekb.lowe@gmail.com 2013-05-23T06:41:12-05:00 hourly 1 2000-01-01T12:00+00:00 http://pipeline.corante.com/archives/2013/05/23/another_look_at_marketing_vs_rd_in_pharma.php FiercePharma has some good figures to back up my posts the other day on R&D spending versus marketing. I mentioned how many people, when they argue that drug companies spend more on marketing than they do on research, are taking... 76434@/home/corante/public_html/pipeline/ Business and Markets 2013-05-23T06:41:12-05:00 http://pipeline.corante.com/archives/2013/05/21/promoting_stem_education_foolishly.php Here's a man who says what he thinks about getting students into STEM careers: The United States spent more than US$3 billion last year across 209 federal programmes intended to lure young people into careers in science, technology, engineering and... 76429@/home/corante/public_html/pipeline/ Current Events 2013-05-21T06:21:12-05:00 http://pipeline.corante.com/archives/2013/05/20/but_dont_drug_companies_spend_more_on_marketing.php So drug companies may spend a lot on R&D, but they spend even more on marketing, right? I see the comments are already coming in to that effect on this morning's post on R&D expenditures as a percentage of revenues.... 76428@/home/corante/public_html/pipeline/ Business and Markets 2013-05-20T10:50:49-05:00 http://pipeline.corante.com/archives/2013/05/20/how_much_do_drug_companies_spend_on_rd_anyway.php How much does Big Pharma spend on R&D, compared to what it takes in? This topic came up during a discussion here last week, when a recent article at The Atlantic referred to these expenditures as "only" 16 cents on... 76427@/home/corante/public_html/pipeline/ Business and Markets 2013-05-20T06:27:33-05:00 http://pipeline.corante.com/archives/2013/05/14/crowdfunding_research.php Crowdfunding academic research might be changing, from a near-stunt to an widely used method of filling gaps in a research group's money supply. At least, that's the impression this article at Nature Jobs gives: The practice has exploded in recent... 76414@/home/corante/public_html/pipeline/ Business and Markets 2013-05-14T07:09:26-05:00 http://pipeline.corante.com/archives/2013/05/13/astellas_closing_the_osi_and_perseid_sites.php I've heard this morning that Astellas is closing the OSI site in Farmingdale, NY, and the Perseid Therapeutics site in Redwood City, CA. More details as I hear them (and check the comments section; people with more direct knowledge may... 76412@/home/corante/public_html/pipeline/ Business and Markets 2013-05-13T10:46:30-05:00 http://pipeline.corante.com/archives/2013/05/06/ken_frazier_at_merck_an_assessment.php Here's a fine profile of Merck's Ken Frazier at Forbes. Matthew Herper does a good job of showing the hole that Merck has been slowly sliding into over the past few years, and wonders if Frazier is going to be... 76391@/home/corante/public_html/pipeline/ Business and Markets 2013-05-06T10:06:57-05:00 http://pipeline.corante.com/archives/2013/04/11/a_startups_postmortem.php Here's an excellent look back by venture capitalist Bruce Booth at one of the companies his firm funded. But this isn't one of those we-exited-with-a-thirtyfold-return stories. On-Q-ity, a diagnostic play, has unfortunately just folded. There were several reasons for this,... 76341@/home/corante/public_html/pipeline/ Business and Markets 2013-04-11T10:46:22-05:00 http://pipeline.corante.com/archives/2013/04/08/pursuing_other_interests_as_they_say.php Sunday isn't usually a big day for announcements from big pharma companies. But yesterday is when Bristol-Myers Squibb let everyone know that their CSO, Elliott Sigal, is retiring. I wonder when he found out - Saturday night? More from FierceBiotech... 76329@/home/corante/public_html/pipeline/ Business and Markets 2013-04-08T06:40:42-05:00 http://pipeline.corante.com/archives/2013/04/04/regeneron_expands.php I feel as if there should be some good news around here on the hiring front, so when any becomes available I want to try to mention it. So here's some: Regeneron has announced today that they're expanding their site... 76326@/home/corante/public_html/pipeline/ Business and Markets 2013-04-04T10:08:28-05:00 http://pipeline.corante.com/archives/2013/04/04/bristolmyers_squibb_closes_down_the_amylin_site.php According to FierceBiotech, Amylin's La Jolla site is to be shut down. People have been getting let go from there for months now, ever since BMS bought them, but now everything must go. That's not what the San Diego region... 76325@/home/corante/public_html/pipeline/ Business and Markets 2013-04-04T09:11:39-05:00 http://pipeline.corante.com/archives/2013/03/28/pfizer_tears_it_all_down.php Yeah, I know, that's a headlines that could have been used several times over the years. But this time, they mean it: the company is demolishing their former research headquarters off Eastern Point Road in Groton. And local officials and... 76310@/home/corante/public_html/pipeline/ Business and Markets 2013-03-28T11:31:44-05:00 http://pipeline.corante.com/archives/2013/03/26/the_wyethelan_insider_trading_case_resolves.php You may remember this insider trading scandal from last year, involving a lead investigator for Wyeth/Elan's trials of bapineuzumab for Alzheimer's. Here's the sequel. The hedge fund involved has agreed to pay $600 million dollars to settle the charges, although... 76304@/home/corante/public_html/pipeline/ Business and Markets 2013-03-26T06:56:53-05:00 http://pipeline.corante.com/archives/2013/03/21/astrazeneca_makes_a_deal_with_moderna_wait_who.php AstraZeneca has announced another 2300 job cuts, this time in sales and administration. That's not too much of a surprise, as the cuts announced recently in R&D make it clear that the company is determined to get smaller. But their... 76293@/home/corante/public_html/pipeline/ Biological News 2013-03-21T06:51:02-05:00 http://pipeline.corante.com/archives/2013/03/19/affymax_in_trouble.php Affymax has had a long history, and it's rarely been dull. The company was founded in 1988, back in the very earliest flush of the Combichem era, and in its early years it (along with Pharmacopeia) was what people thought... 76285@/home/corante/public_html/pipeline/ Business and Markets 2013-03-19T07:15:02-05:00